Eudaimonia Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,053
| Closed | -$229K | – | 286 |
|
|
2023
Q3 | $229K | Buy |
3,053
+183
| +6% | +$13.7K | 0.06% | 280 |
|
|
2023
Q2 | $221K | Sell |
2,870
-263
| -8% | -$20.3K | 0.05% | 304 |
|
|
2023
Q1 | $260K | Sell |
3,133
-829
| -21% | -$68.8K | 0.06% | 275 |
|
|
2022
Q4 | $340K | Sell |
3,962
-248
| -6% | -$21.3K | 0.08% | 234 |
|
|
2022
Q3 | $260K | Sell |
4,210
-313
| -7% | -$19.3K | 0.07% | 262 |
|
|
2022
Q2 | $280K | Buy |
4,523
+1,103
| +32% | +$68.3K | 0.05% | 304 |
|
|
2022
Q1 | $203K | Buy |
+3,420
| New | +$203K | 0.03% | 381 |
|
|
2021
Q2 | – | Sell |
-3,162
| Closed | -$204K | – | 757 |
|
|
2021
Q1 | $204K | Sell |
3,162
-894
| -22% | -$57.7K | 0.04% | 331 |
|
|
2020
Q4 | $236K | Sell |
4,056
-4,560
| -53% | -$265K | 0.05% | 278 |
|
|
2020
Q3 | $544K | Buy |
8,616
+4,588
| +114% | +$290K | 0.14% | 159 |
|
|
2020
Q2 | $310K | Sell |
4,028
-761
| -16% | -$58.6K | 0.12% | 181 |
|
|
2020
Q1 | $358K | Buy |
4,789
+1,771
| +59% | +$132K | 0.16% | 155 |
|
|
2019
Q4 | $196K | Buy |
+3,018
| New | +$196K | 0.08% | 239 |
|